PT  - JOURNAL ARTICLE
AU  - Kim, Seung-Tae
AU  - Chon, Hong Jae
AU  - Oh, Do-Youn
AU  - Grewal, Jaspreet
AU  - Rha, Sun Young
AU  - El-Khoueiry, Anthony
AU  - Ryoo, Baek-Yeol
AU  - Kim, Jeongjun
AU  - Ahn, Hyunji
AU  - Ryu, Seung-Hee
AU  - Choi, Jinho
AU  - Choi, Bae Jung
AU  - Ahn, Jiye
AU  - Kang, Hwankyu
AU  - Yang, Yeong-In
AU  - Lee, Seung-Joo
AU  - Jeon, Borami
AU  - Proniuk, Stefan
AU  - Nam, Kiyean
TI  - 645 A phase 1B/2, open-label study of Q702 in combination with intravenous pembrolizumab in patients with selected advanced solid tumors
AID  - 10.1136/jitc-2023-SITC2023.0645
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A738--A738
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A738.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A738.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.